Shardul Amarchand Mangaldas advised DXN Holdings Bhd. on the deal. DXN Holdings Bhd. (“DXN”) on its initial public offering of up to 932,675,000 ordinary shares (“IPO”),...
You must be a Standard 1 Year member to access this content.
Shardul Amarchand Mangaldas & Co. advised Raymond Consumer Care Limited on the deal. Raymond Consumer Care Limited complited the transfer of it’s FMCG business undertaking (which...
You must be a Standard 1 Year member to access this content.
Shardul Amarchand Mangaldas advised Raymond Limited on the deal. Raymond Limited and Raymond Luxury Cottons Limited were part of the buy-back process for RLCL, with the...
You must be a Standard 1 Year member to access this content.
Shardul Amarchand Mangaldas & Co. advised LeapFrog Investments on the deal. LeapFrog Investments executed a $31.1 million Series C round of investment in Medgenome Inc., which was led...
You must be a Standard 1 Year member to access this content.
